bioRxivBioinformaticsPreprint
Identifying Representative Cell Line Models for TNBC Chemotherapy Drug Resistance via Systems Biology and Bioinformatics
Abstract
Cancer cell lines, derived from tumors, have become essential tools in life science research and are commonly employed as experimental model systems in cancer research. However, researchers often overlook the similarities between clinical samples when selecting cell line models, potentially impacting the validity and applicability of their findings. In the context of triple-negative breast cancer (TNBC) chemotherapy drug resistance, our study aims to provide guidance for selecting appropriate cell line models by employing a combination of systems biology and bioinformatic approaches. These approaches, including hierarchical clustering analysis, Spearmans rank correlation, and single sample gene set enrichment analysis (ssGSEA), allowed us to identify the most representative cell models that correspond to poor chemotherapy responders among TNBC patients.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Resistance patterns in drug-adapted cancer cell lines reflect complex evolution in clinical tumors
H. E. Grimsley, M. Antczak, … M. Michaelis·bioRxiv·Jan 20, 2024
- Contribution of Mesenchymal-like and Epithelial Cellular Subsets to Chemotherapy Resistance in Triple-Negative Breast Cancer
Ngoc Bao Vuong, Olga Y. Korolkova, … Amos M. Sakwe·bioRxiv·Nov 1, 2025
- Deciphering the gene regulatory circuitry governing chemoresistance in Triple-Negative Breast Cancer
R. Lusby, A. Mariappan, … V. K. Tiwari·bioRxiv·May 5, 2023
- A Network Approach to Identify Biomarkers of Differential Chemotherapy Response Using Patient-Derived Xenografts of Triple-Negative Breast Cancer
V. Petrosyan, L. E. Dobrolecki, … M. T. Lewis·bioRxiv·Aug 20, 2021
- Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance
F. Lamballe, F. Ahmad, … F. Maina·bioRxiv·Jun 22, 2020
- Chemoresistance to additive PARP/PI3K dual inhibition in triple-negative breast cancer cell lines is associated with adaptive stem cell-like prevalence
Paula E. Petrella, Jason W. Chen, … Benjamin D. Cosgrove·bioRxiv·Apr 28, 2024